C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 303/36 (2006.01) A61K 31/336 (2006.01) A61K 31/409 (2006.01) A61K 31/428 (2006.01) A61K 31/4375 (2006.01) A61K 31/4427 (2006.01) A61K 31/4725 (2006.01) A61K 31/497 (2006.01) A61K 31/501 (2006.01) A61K 31/506 (2006.01) C07D 405/12 (2006.01) C07D 407/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2755910
The invention relates to compounds of formulae (1) and (2), and pharmaceutically acceptable salts thereof for the treatment of cancer, inflammation, auto-immune diseases, diabetes and diabetic complications, infection, cardiovascular disease and ischemia-reperfusion injuries.
La présente invention concerne des composés de formule (1) et (2), ainsi que leurs sels pharmaceutiquement acceptables, utilisables dans le cadre du traitement du cancer, de l'inflammation, des maladies auto-immunes, du diabète et de ses complications, de l'infection, des maladies cardiovasculaires et des lésions d'ischémie-reperfusion.
Ducker Charles E.
Sliskovic D. Robert
Zhang Jie
Gowling Lafleur Henderson Llp
Profectus Biosciences Inc.
LandOfFree
Inhibitors of nf-kb does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of nf-kb, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of nf-kb will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1528715